344 related articles for article (PubMed ID: 23622367)
21. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis.
Marhaug G; Shah V; Shroff R; Varsani H; Wedderburn LR; Pilkington CA; Brogan PA
Rheumatology (Oxford); 2008 Jul; 47(7):1031-7. PubMed ID: 18448482
[TBL] [Abstract][Full Text] [Related]
22. [A case of juvenile dermatomyositis with calcinosis universalis--remarkable improvement with aluminum hydroxide therapy].
Aihara Y; Mori M; Ibe M; Kuriyama T; Takahashi Y; Shimizu C; Shike H; Mitsuda T; Yokota S
Ryumachi; 1994 Oct; 34(5):879-84. PubMed ID: 7801200
[TBL] [Abstract][Full Text] [Related]
23. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
[TBL] [Abstract][Full Text] [Related]
24. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
25. [Juvenile dermatomyositis].
Bukovac LT; Perica M; Vidović M; Lamot L; Harjacek M
Reumatizam; 2012; 59(2):63-72. PubMed ID: 23745459
[TBL] [Abstract][Full Text] [Related]
26. Clinical spectrum of inflammatory myositis in South India--a ten year study.
Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P
J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209
[TBL] [Abstract][Full Text] [Related]
27. Duration of illness is an important variable for untreated children with juvenile dermatomyositis.
Pachman LM; Abbott K; Sinacore JM; Amoruso L; Dyer A; Lipton R; Ilowite N; Hom C; Cawkwell G; White A; Rivas-Chacon R; Kimura Y; Ray L; Ramsey-Goldman R
J Pediatr; 2006 Feb; 148(2):247-53. PubMed ID: 16492437
[TBL] [Abstract][Full Text] [Related]
28. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
Wienke J; Deakin CT; Wedderburn LR; van Wijk F; van Royen-Kerkhof A
Front Immunol; 2018; 9():2951. PubMed ID: 30619311
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
Tayfur AC; Topaloglu R; Gulhan B; Bilginer Y
Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
[TBL] [Abstract][Full Text] [Related]
30. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
Sanner H; Sjaastad I; Flatø B
Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
[TBL] [Abstract][Full Text] [Related]
32. [Juvenile dermatomyositis].
Tambić-Bukovac L; Malcić I; Prohić A
Reumatizam; 2001; 48(1):27-33. PubMed ID: 12476739
[TBL] [Abstract][Full Text] [Related]
33. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
[TBL] [Abstract][Full Text] [Related]
34. Juvenile dermatomyositis in north India.
Singh S; Kumar L; Shankar KR
Indian Pediatr; 1997 Mar; 34(3):193-8. PubMed ID: 9282485
[TBL] [Abstract][Full Text] [Related]
35. Juvenile Dermatomyositis and the Inflammatory Myopathies.
Swafford C; Roach ES
Semin Neurol; 2020 Jun; 40(3):342-348. PubMed ID: 32252099
[TBL] [Abstract][Full Text] [Related]
36. [Myositis and the skin: cutaneous manifestations of dermatomyositis].
Jinnin M
Brain Nerve; 2013 Nov; 65(11):1283-90. PubMed ID: 24200606
[TBL] [Abstract][Full Text] [Related]
37. A rare complication of generalized edema in juvenile dermatomyositis: a report of one case.
Karabiber H; Aslan M; Alkan A; Yakinci C
Brain Dev; 2004 Jun; 26(4):269-72. PubMed ID: 15130694
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
Al-Mayouf SM; AlMutiari N; Muzaffer M; Shehata R; Al-Wahadneh A; Abdwani R; Al-Abrawi S; Abu-Shukair M; El-Habahbeh Z; Alsonbul A
Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
[TBL] [Abstract][Full Text] [Related]
39. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.
Smith RL; Sundberg J; Shamiyah E; Dyer A; Pachman LM
J Rheumatol; 2004 Aug; 31(8):1644-9. PubMed ID: 15290747
[TBL] [Abstract][Full Text] [Related]
40. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?
Prasad S; Misra R; Agarwal V; Lawrence A; Aggarwal A
Int J Rheum Dis; 2013 Oct; 16(5):556-60. PubMed ID: 24164843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
